Role of microRNA 21 in diabetes and associated/related diseases

Gene

Volumn 582, Issue 1, 2016, Pages 14-18

  Sekar, Durairaj ^a   Venugopal, Basam ^a   Sekar, Punitha ^a   Ramalingam, Krishnan ^b  

^a Cryovault Biotech Pvt Ltd   (India)

^b NARAYANA MEDICAL COLLEGE   (India)

Author keywords

Cell proliferation; Diabetes mellitus; MicroRNAs; MiR 21; PTEN; RNAs

Indexed keywords

MICRORNA 21; ANTIDIABETIC AGENT; INSULIN; MICRORNA; MIRN21 MICRORNA, HUMAN;

APOPTOSIS; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; DIABETIC PATIENT; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; DIABETES MELLITUS; GENETICS;

APOPTOSIS; CELL PROLIFERATION; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MICRORNAS; OBESITY;

EID: 84959118263     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.01.039     Document Type: Review

References (43)

1. Azevedo M., Alla S. Diabetes in sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int. J. Diabetes Dev. Ctries 2008, 28(4):101-108.
2. Backe M.B., et al. Altering beta-cell number through stable alteration of miR-21 and miR-34a expression. Islets 2014, 6(1).
3. Bacon S., et al. MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential indicator of beta-cell demise. Genes (Basel) 2015, 6(2):399-416.
4. Bai C., et al. Role of microRNA-21 in the formation of insulin-producing cells from pancreatic progenitor cells. Biochim. Biophys. Acta 2015, 1859(2):280-293.
5. Balasubramanyam M., et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol. Cell. Biochem. 2011, 351(1-2):197-205.
6. Baldeon Rojas L., et al. Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. Diabetol. Metab. Syndr. 2016, 8:6.
7. Chakraborty C., George Priya Doss C., Bandyopadhyay S. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr. Drug Targets 2013, 14(10):1110-1117.
8. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65(14):6029-6033.
9. Dey N., et al. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J. Biol. Chem. 2011, 286(29):25586-25603.
10. Feng B., et al. Reprint of: miRNA-1 regulates endothelin-1 in diabetes. Life Sci. 2014, 118(2):275-280.
11. Filios S.R., et al. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. J. Biol. Chem. 2014, 289(52):36275-36283.
12. Fiorentino L., et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol. 2013, 50(6):965-969.
13. Foley N.H., O'Neill L.A. miR-107: a toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes. J. Leukoc. Biol. 2012, 92(3):521-527.
14. Huang Y., et al. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol. 2014, 15:142.
15. Kantharidis P., et al. Diabetes complications: the microRNA perspective. Diabetes 2011, 60(7):1832-1837.
16. Kim Y.J., et al. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009, 27(12):3093-3102.
17. Lai J.Y., et al. MicroRNA-21 in glomerular injury. J. Am. Soc. Nephrol. 2015, 26(4):805-816.
18. Li X. MiR-375, a microRNA related to diabetes. Gene 2014, 533(1):1-4.
19. Madhyastha R., et al. MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration. Int. Wound J. 2012, 9(4):355-361.
20. McClelland A.D., et al. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin. Sci. (Lond.) 2015, 129(12):1237-1249.
21. Meng S., et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J. Mol. Cell. Cardiol. 2012, 53(1):64-72.
22. Meng S., et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 2013, 8(7).
23. Nakashima N., et al. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 2000, 275(17):12889-12895.
24. Olokoba A.B., Obateru O.A., Olokoba L.B. Type 2 diabetes mellitus: a review of current trends. Oman Med. J. 2012, 27(4):269-273.
25. Osipova J., et al. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J. Clin. Endocrinol. Metab. 2014, 99(9):E1661-E1665.
26. Place R.F., et al. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(5):1608-1613.
27. Qing S., et al. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cell. Physiol. Biochem. 2014, 34(5):1733-1740.
28. Roy S., et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 2009, 82(1):21-29.
29. Ruan Q., et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(29):12030-12035.
30. Saravanan S., et al. miRNA-24 and miRNA-466i-5p controls inflammation in rat hepatocytes. Cell. Mol. Immunol. 2015, 12(1):113-115.
31. Scheen A.J., Van Gaal L.F. Type 2 diabetes, in the heart of the metabolic syndrome: plea for a global approach. Rev. Med. Liege 2005, 60(5-6):566-571.
32. Schwarz P.E., et al. The metabolic syndrome-a global challenge for prevention. Horm. Metab. Res. 2007, 39(11):777-780.
33. Sebastiani G., et al. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetol. 2015, 52(3):523-530.
34. Sekar D., et al. Relevance of miR-21 in HIV and non-HIV-related lymphomas. Tumour Biol. 2014, 35(9):8387-8393.
35. Sekar D., et al. Role of microRNA 21 in mesenchymal stem cell (MSC) differentiation: a powerful biomarker in MSCs derived cells. Curr. Pharm. Biotechnol. 2015, 16(1):43-48.
36. Si M.L., et al. miR-21-mediated tumor growth. Oncogene 2007, 26(19):2799-2803.
37. Tang X., et al. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3 T3-L1 adipocytes. J. Biol. Chem. 2005, 280(23):22523-22529.
38. Tome-Carneiro J., et al. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res. 2013, 72:69-82.
39. Wang X., et al. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS One 2014, 9(1).
40. Wu H., et al. The role of microRNAs in diabetic nephropathy. J. Diabetes Res. 2014, 2014:920134.
41. Zhang Z., et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 2009, 583(12):2009-2014.
42. Zhong X., et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013, 56(3):663-674.
43. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.